Brief: NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines
10/10/2017 03:53
Oct 10 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T
* Says it and NanoCarrier Co., Ltd 4571.T conclude
collaborative research agreement for drug delivery to the brain
for nucleic acid medicines
* Under this agreement, Nanocarrier and JCR will integrate
the unique technologies and knowledge of both companies, and aim
to develop an innovative drug effectively delivered to the brain
Source text in Japanese:https://goo.gl/WhdMns
Further company coverage: 4552.T 4571.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))